1. Prognosticating 2-Year Survival Rate of Breast Cancer Patients Through Plasma miRNA-21 and Other Associating Factors
   Pradana Zaky Romadhon et al, 2022, International Journal of General Medicine CrossRef
2. Diagnostic impact of CEA and CA 15-3 on monitoring chemotherapy of breast cancer patients
   Diya Hasan, 2022, Journal of Circulating Biomarkers CrossRef
3. A Phenomic Perspective on Factors Influencing Breast Cancer Treatment: Integrating Aging and Lifestyle in Blood and Tissue Biomarker Profiling
   Ainhoa Arana Echarri et al, 2021, Frontiers in Immunology CrossRef
4. Liquid Biopsy as a Tool for the Diagnosis, Treatment, and Monitoring of Breast Cancer
   Ana Julia Aguiar de Freitas et al, 2022, International Journal of Molecular Sciences CrossRef
5. Association between CA 15‑3 and progression of interstitial lung disease in a case of coexisting systemic sclerosis and recurrent breast cancer: A case report
   Masahiro Ohara et al, 2022, Molecular and Clinical Oncology CrossRef
6. Effect of Eremomastax polysperma on some Tumour Markers of 7,12-Dimethylbenz(A) Anthracene Induced Mammary Carcinogenesis in Female Rats
   Udiomine Brantley Akuru et al, 2022, Research Journal of Medicinal Plants CrossRef
7. KRT19 and CEACAM5 mRNA-marked circulated tumor cells indicate unfavorable prognosis of breast cancer patients
   Xi-Mei Wang et al, 2019, Breast Cancer Research and Treatment CrossRef
8. Significance of serum carcinoembryonic antigen in metastatic breast cancer patients: A prospective study
   Thattungal Manoharan Anoop et al, 2022, World Journal of Clinical Oncology CrossRef
9. Overview of Utilization of Tumor Markers for Cancer Diagnosis
   Hong Sung Kim, 2022, Biomedical Science Letters CrossRef